TY  - GEN 
AU  - Durán, I.
AU  - Castellano, D.
AU  - Puente, J.
AU  - Martín-Couce, L.
AU  - Bello, E.
AU  - Anido Herranz, Urbano
AU  - Mas, J.M.
AU  - Costa, L.
PY  - 2022
SN  - 1949-2553
UR  - http://hdl.handle.net/20.500.11940/19612
AB  - Clinical evidence supports the combination of cabozantinib with an immune checkpoint inhibitor for the treatment of metastatic clear cell renal cell carcinoma (mccRCC) and suggests a synergistic antitumour activity of this combination. Nevertheless,...
LA  - en
TI  - Exploring the synergistic effects of cabozantinib and a programmed cell death protein 1 inhibitor in metastatic renal cell carcinoma with machine learning
DO  - 10.18632/ONCOTARGET.28183
KW  - AS Santiago
KW  - CHUS
KW  - IDIS
VL  - 13
ER  -